SUMMIT THERAPEUTICS INC.
Profile
Company Names
SUMMIT THERAPEUTICS INC.
SUMMIT THERAPEUTICS PLC
SUMMIT CORP PLC
Addresses
601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL 33131
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE, MA 02142
136A EASTERN AVENUE, MILTON PARK, ABINGDON, X0 OX14 4SB
85B PARK DRIVE, MILTON PARK, ABINGDON, X0 OX14 4RY
Phone Numbers
305-203-2034
617-514-7149
44-123-544-3939
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
> 5 years ago
State Incorporated:
UNITED KINGDOM
Total Amount Raised:
$569,043,887.00
Number of Funding Rounds:
6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2024-09-11
$234,999,889.00
$234,999,889.00
$0.00
Equity
5
2024-06-03
$199,999,998.00
$199,999,998.00
$0.00
Equity
4
2020-11-06
$50,000,000.00
$50,000,000.00
$0.00
Equity
3
2019-12-24
$47,400,000.00
$47,400,000.00
$0.00
Equity
2
2019-01-09
$25,000,000.00
$25,000,000.00
$0.00
Equity
1
2014-03-04
$11,644,000.00
$11,644,000.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT
DUGGAN
EXECUTIVE OFFICER, DIRECTOR
MEDABLE INC.
| SUMMIT THERAPEUTICS INC.
| PULSE BIOSCIENCES, INC.
| HAVEN COVE ABSOLUTE RETURN FUND
| OXFORD FINANCE CREDIT FUND III LP
| AXEBROOK CREDIT ALPHA FUND LTD
| AXEBROOK CREDIT ALPHA FUND, L.P.
| PEARLSTONE ALTERNATIVE FUND L.P.
| STEMPOINT CAPITAL OFFSHORE FUND LTD
| SIGNAL BEACON ABS FUND
| SIGNAL BEACON FUND
| ANAVIO EQUITY CAPITAL MARKETS FUND LP
| AXIOM VENTURE FUND I LP
| PARDINUS LONG SHORT EUROPEAN EQUITY FEEDER FUND LP
| KINGSWAY FRONTIER CONSUMER OPPORTUNITIES (FCO4) GROWTH FUND IV LTD
| FIDERA VECTA US FEDERAL AGENCY RECEIVABLES FUND LP
| BLIXT FUND II LP
| FIDERA OPPORTUNITIES FEEDER FUND LTD
| AQT CAPITAL OFFSHORE FUND, LTD.
| LINGOTTO INNOVATION FUND LP
JEFF
HUBER
DIRECTOR
VCD 88, LLC
| GC 245, LLC
| KIRK 175, LLC
| 8M4S23, LLC
| LS 103RD 230, LLC
| NORTH BEACH 610, LLC
| PAC HWY 330 LLC
| PAC HWY 630, LLC
| PRIVATE CAPITAL NORTHWEST, LLC
| MP 455, LLC
| ALDER 430, LLC
| ALDERWOOD 3500, LLC
| MUNCHKIN 360, LLC
| ALDERWOOD CENTER LENDERS, LLC
| BP 520, LLC
| WOOD 300, LLC
| EVERPLEX 235, LLC
| KENMORE 455, LLC
| SHELL 1000, LLC
| GRANDVIEW 590, LLC
| SL 210, LLC
| 23RD AVE 305, LLC
| 204TH SHORELINE, LLC
| KENMORE 62ND, LLC
| LIBERTY 400, LLC
| PACIFIC NORTHWEST LENDERS, LLC
| TETONIA 325, LLC
| COLBY 365, LLC
| 145TH 275, LLC
| GUIDE 950, LLC
| EPHRATA 310, LLC
| EAST K STREET 215, LLC
| MEEKER 890, LLC
| CM 1200, LLC
| SOUTH PUGET SOUND 240, LLC
| FINN HILL 3050, LLC
| ELEMENT 2B 750, LLC
| 204TH SHORELINE 315, LLC
| RENTON WESTGATE 275, LLC
| STANWOOD 560, LLC
| GRANDVIEW PATEROS, LLC
| 48TH AVENUE SOUTH 500, LLC
| SUNSET 1725, LLC
| TACOMA STATION 580, LLC
| CHINDEN 280, LLC
| COMMERCIAL 150, LLC
| MARYSVILLE 250, LLC
| DEER PARK 271, LLC
| MADISON 550, LLC
| VAUGHN 280, LLC
| LAKEVIEW 4450, LLC
| GRANDPAD INC.
| QUINN 300, LLC
| STANWOOD 510, LLC
| STANWOOD 800, LLC
| HIGHLANDS 850, LLC
| GRANDVIEW 295, LLC
| DISCOVER ECHO INC.
| GRANDVIEW 545, LLC
| SHORELINE 345, LLC
| 3849 CHINDEN 500, LLC
| AUGUSTA 145, LLC
| 11TH STREET 350, LLC
| STANWOOD 705, LLC
| COLBY 410, LLC
| OH 160, LLC
| AUGUSTA 156, LLC
| TYEE 185, LLC
| WOODLAKE 295, LLC
| MI 885, LLC
| CONCRETE 170, LLC
| MANIFOLD BIOTECHNOLOGIES, INC.
| ZAPATA COMPUTING, INC.
| SUMMIT THERAPEUTICS INC.
| EDISON SCIENTIFIC, INC.
JIM
MELLON
DIRECTOR
DAVID
ROBLIN
EXECUTIVE OFFICER
MOSTAFA
RONAGHI
DIRECTOR
MANMEET
SONI
DIRECTOR, EXECUTIVE OFFICER
RAYMOND
SPENCER
EXECUTIVE OFFICER
DAVID
WURZER
DIRECTOR
MAHKAM
ZANGANEH
DIRECTOR, EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-09-11
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-06-03
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$1,000,001 - $5,000,000
Equity
2020-11-06
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-12-24
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-01-09

